Bio-Techne (TECH) Misses Q2 EPS by 18c

Bio-Techne (NASDAQ: TECH) reported Q2 EPS of $0.31, $0.18 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $271.58 million versus the consensus estimate of $289.54 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c